Free Trial
→ The Social Security Changes No One’s Talking About (From Altimetry) (Ad)

15 Healthcare Stocks that Analysts Love in a Post-Pandemic World - 2 of 15

Slide 2
Back to 1
Continue to 3
 
Back to 1
Continue to 3
 

Sanofi (NASDAQ:SNY)

Consensus Rating
Buy
Rating Score
3.1
Ratings Breakdown
5 Buy Ratings, 2 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$63.33 (28.2% Upside)

About Sanofi

Sanofi logoSanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products. More about Sanofi
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
4/28/2025Hsbc Global ResUpgradeStrong-Buy
4/15/2025BNP ParibasInitiated CoverageOutperform$65.00
3/21/2025The Goldman Sachs GroupInitiated CoverageNeutral$65.00
1/30/2025Sanford C. BernsteinUpgradeStrong-Buy
1/30/2025Deutsche Bank AktiengesellschaftUpgradeSell ➝ Hold
9/17/2024CitigroupUpgradeStrong-Buy
7/26/2024ArgusBoost Price TargetBuy ➝ Buy$55.00 ➝ $60.00
1/23/2024Morgan StanleyInitiated CoverageEqual Weight$55.00
12/5/2023JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral
10/30/2023Stifel NicolausDowngradeBuy ➝ Hold
Slide 2
Back to 1
Continue to 3
 

More From MarketBeat
Trump Just Gave the Green Light to Rewrite Social Security?
In a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...
Altimetry | Sponsored
Profit Without Panic: 7 ETFs to Diversify Your Portfolio
Many investors find fund investing to be a sound alternative to the ups and downs that come with owning...
MarketBeat
Banks aren’t ready for this altcoin—are you?
I've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...
Crypto 101 Media | Sponsored
7 Defensive Stocks to Shield Your Portfolio from Inflation
Inflation is an unavoidable consequence of a market-based economy. In the best case, inflation is fueled by ...
MarketBeat
The “supermetal” that could power AI
While the headlines focus on AI models and chip speed, Elon Musk is investing in the material side of the stor...
True Market Insiders | Sponsored
10 Cheap Dividend Stocks to Buy Today
The stock market has always been unpredictable, but unprecedented world events have made the market even more ...
MarketBeat